Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Linquan Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6272-6208; OpenAlex author ID A5101926891. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. TRIM29 may facilitate progression of pancreatic ductal adenocarcinoma through immune remodeling. Last author DOI 10.1016/j.pan.2026.10.006↗
  2. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer … Co-author DOI 10.3892/or.2018.6760↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuaiwu Luo · 1 shared paper, 2026 · strength 0.28
  2. Jun Yang · 1 shared paper, 2026 · strength 0.28
  3. Pengcheng Zhou · 1 shared paper, 2026 · strength 0.28
  4. Yonghao Xu · 1 shared paper, 2026 · strength 0.28
  5. Yeqing Zou · 1 shared paper, 2018 · strength 0.08
  6. Xiangbao Yin · 1 shared paper, 2018 · strength 0.08
  7. Fan Zhou · 1 shared paper, 2018 · strength 0.08
  8. Zhiwei Zhong · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.